Robert J. Cardnell, Ph.D.
Affiliations: | 2006 | Rice University, Houston, TX |
Area:
Drosophila Neuro-geneticsGoogle:
"Robert Cardnell"Mean distance: 17.37 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentorMichael Stern | grad student | 2006 | Rice University | |
(In vivo analysis of gain-of-function mutations in the Drosophila eag-encoded potassium ion channel.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Morris BB, Heeke S, Xi Y, et al. (2024) DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer. Biorxiv : the Preprint Server For Biology |
Stewart CA, Diao L, Xi Y, et al. (2024) YAP1 status defines two intrinsic subtypes of LCNEC with distinct molecular features and therapeutic vulnerabilities. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Ramkumar K, Tanimoto A, Della Corte CM, et al. (2023) Targeting BCL2 overcomes resistance and augments response to aurora kinase B inhibition by AZD2811 in small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Zhang B, Stewart CA, Wang Q, et al. (2022) Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer. British Journal of Cancer |
Della Corte CM, Fasano M, Ciaramella V, et al. (2022) Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial. Journal of Experimental & Clinical Cancer Research : Cr. 41: 109 |
Kundu K, Cardnell RJ, Zhang B, et al. (2021) SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer. Translational Lung Cancer Research. 10: 4095-4105 |
Chen M, Chen R, Jin Y, et al. (2021) Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer. Nature Communications. 12: 6655 |
Cargill KR, Stewart CA, Park EM, et al. (2021) Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer. Cancer & Metabolism. 9: 33 |
Zhang B, Ramkumar K, Cardnell RJ, et al. (2021) A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers. British Journal of Cancer |
Stewart CA, Gay CM, Ramkumar K, et al. (2021) Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |